While the results of our meta-analysis revealed that ACE rs4646994 polymorphism was associated with the risk of DCM/HCM incidence, providing a rationale of genetic aspects for the treatment of DCM/HCM. This evidence concerns the gene ACE and familial dilated cardiomyopathy.